LncRNA HITT (HIF1A inhibitor at translation level) directly interacts with ataxia-telangiectasia mutated (ATM) and suppresses homologous recombination repair in human colon cancer tissues [164]. This evidence concerns the gene HIF1A and malignant colon neoplasm.